603538 美诺华
已收盘 08-21 15:00:00
资讯
新帖
简况
美诺华：JH389的欧洲注册是公司同欧洲合作方共同推进的
证券之星 · 08-21 16:09
美诺华：JH389的欧洲注册是公司同欧洲合作方共同推进的
美诺华：默沙东新合作品种正不断进入
证券之星 · 08-21 16:00
美诺华：默沙东新合作品种正不断进入
异动快报：美诺华（603538）8月21日9点33分触及跌停板
证券之星 · 08-21 09:35
异动快报：美诺华（603538）8月21日9点33分触及跌停板
8月20日美诺华涨5.85%，富国致航量化选股股票A基金重仓该股
证券之星 · 08-20 16:35
8月20日美诺华涨5.85%，富国致航量化选股股票A基金重仓该股
美诺华（603538）披露召开2026年第二次临时股东会通知，8月18日股价下跌1.25%
证券之星 · 08-18
美诺华（603538）披露召开2026年第二次临时股东会通知，8月18日股价下跌1.25%
【机构调研记录】银河基金调研美诺华、多利科技
证券之星 · 08-17
【机构调研记录】银河基金调研美诺华、多利科技
【机构调研记录】华宝基金调研美诺华、多利科技
证券之星 · 08-17
【机构调研记录】华宝基金调研美诺华、多利科技
【私募调研记录】玄卜投资调研美诺华
证券之星 · 08-17
【私募调研记录】玄卜投资调研美诺华
【私募调研记录】季胜投资调研美诺华
证券之星 · 08-17
【私募调研记录】季胜投资调研美诺华
【私募调研记录】翼虎投资调研美诺华
证券之星 · 08-17
【私募调研记录】翼虎投资调研美诺华
每周股票复盘：美诺华（603538）近5日4次登龙虎榜
证券之星 · 08-16
每周股票复盘：美诺华（603538）近5日4次登龙虎榜
8月14日美诺华（603538）龙虎榜数据：北向资金净卖出2174.12万元
证券之星 · 08-14
8月14日美诺华（603538）龙虎榜数据：北向资金净卖出2174.12万元
8月13日美诺华（603538）龙虎榜数据：北向资金净卖出1759.38万元
证券之星 · 08-13
8月13日美诺华（603538）龙虎榜数据：北向资金净卖出1759.38万元
美诺华（603538）2026年中报简析：营收净利润同比双双增长，应收账款上升
证券之星 · 08-13
美诺华（603538）2026年中报简析：营收净利润同比双双增长，应收账款上升
美诺华(603538)6月30日股东户数4.41万户，较上期减少15.96%
证券之星 · 08-12
美诺华(603538)6月30日股东户数4.41万户，较上期减少15.96%
8月12日美诺华涨10.00%，富国致航量化选股股票A基金重仓该股
证券之星 · 08-12
8月12日美诺华涨10.00%，富国致航量化选股股票A基金重仓该股
异动快报：美诺华（603538）8月12日9点33分触及涨停板
证券之星 · 08-12
异动快报：美诺华（603538）8月12日9点33分触及涨停板
图解美诺华中报：第二季度单季净利润同比增长16.86%
证券之星 · 08-12
图解美诺华中报：第二季度单季净利润同比增长16.86%
美诺华（603538）披露《公司章程》（2026年8月修订版），8月11日股价上涨3.77%
证券之星 · 08-11
美诺华（603538）披露《公司章程》（2026年8月修订版），8月11日股价上涨3.77%
公告精选︱工业富联：上半年净利润237.4亿元，同比增长95.99%；宝鼎科技：无AI覆铜板，未发现在AI服务器及算力领域的应用
格隆汇 · 08-11
公告精选︱工业富联：上半年净利润237.4亿元，同比增长95.99%；宝鼎科技：无AI覆铜板，未发现在AI服务器及算力领域的应用
加载更多
公司概况
公司名称：
宁波美诺华药业股份有限公司
所属行业：
医药制造业
上市日期：
2017-04-07
主营业务：
宁波美诺华药业股份有限公司的主营业务是特色原料药和制剂研发、生产与销售。公司的主要产品是医药中间体、原料药、制剂。公司是中国化学制药百强企业、宁波市制造业百强企业、宁波竞争力百强企业、浙江省成长最快百强企业。
发行价格：
14.03
{"stockData":{"symbol":"603538","market":"SH","secType":"STK","nameCN":"美诺华","latestPrice":28.51,"timestamp":1787295600000,"preClose":31.68,"halted":0,"volume":43157519,"delay":0,"changeRate":-0.1001,"floatShares":337000000,"shares":340000000,"eps":0.3438,"marketStatus":"已收盘","change":-3.17,"latestTime":"08-21 15:00:00","open":29.92,"high":30,"low":28.51,"amount":1236000000,"amplitude":0.047,"askPrice":28.51,"askSize":52721,"bidPrice":0,"bidSize":0,"shortable":0,"etf":0,"ttmEps":0.3438,"tradingStatus":0,"nextMarketStatus":{"tag":"开盘","tradingStatus":2,"beginTime":1787535000000},"marketStatusCode":5,"adr":0,"adjPreClose":31.68,"symbolType":"stock","openAndCloseTimeList":[[1787275800000,1787283000000],[1787288400000,1787295600000]],"highLimit":34.85,"lowLimit":28.51,"ibTradeSell":false,"ibTradeBuySell":true,"totalEquity":339928188,"isCdr":false,"pbRate":3.31,"roa":"--","peRate":82.92612,"roe":"2.42%","epsLYR":0.48,"committee":0,"marketValue":9691000000,"turnoverRate":0.1281,"status":1,"nextConnectDate":"根据港交所公布的数据，今日已停止北向交易，下一个交易日为北京时间 2026-08-24。","floatMarketCap":9606000000},"requestUrl":"/m/hq/s/603538","defaultTab":"news","newsList":[{"id":"2661963263","title":"美诺华：JH389的欧洲注册是公司同欧洲合作方共同推进的","url":"https://stock-news.laohu8.com/highlight/detail?id=2661963263","media":"证券之星","labels":["corporation"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661963263?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:09","pubTimestamp":1787299755,"startTime":"0","endTime":"0","summary":"JH389的欧洲注册是公司同欧洲合作方共同推进的，目前已与EFSA进行了数轮预沟通。受欧洲合作方安排影响，目前仍有一项注册前的安全性试验正在进行中。截至目前，无论是已完成的试验、尚在进行的试验，还是与EFSA的沟通，均未收到任何关于安全性或技术性的负面反馈。此后，JH389将成为美诺华独有的特色创新管线产品。本次收购充分体现了公司对JH389项目的坚定推进决心，未来将更高效地统筹项目的生产、注册及销售布局，力争尽快实现销售收入。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100026444.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"corporation","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661531263","title":"美诺华：默沙东新合作品种正不断进入","url":"https://stock-news.laohu8.com/highlight/detail?id=2661531263","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661531263?lang=zh_cn&edition=full","pubTime":"2026-08-21 16:00","pubTimestamp":1787299253,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华08月21日在投资者关系平台上答复投资者关心的问题。默沙东的业务今年有不错的进展，主要是前期的一个大产品已经进入了商业化阶段。新合作品种正在不断进入，公司将进一步深化与默沙东的战略合作关系，成为亚太地区创新性小分子药物的核心生产基地，业绩会逐步兑现。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100025565.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2661256352","title":"异动快报：美诺华（603538）8月21日9点33分触及跌停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2661256352","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2661256352?lang=zh_cn&edition=full","pubTime":"2026-08-21 09:35","pubTimestamp":1787276133,"startTime":"0","endTime":"0","summary":"证券之星8月21日盘中消息，9点33分美诺华（603538）触及跌停板。其所属行业化学制药目前上涨。领涨股为键凯科技。该股为辅助生殖，新冠病毒防治，合成生物概念热股。8月20日的资金流向数据方面，主力资金净流入1.31亿元，占总成交额4.92%，游资资金净流出4684.48万元，占总成交额1.77%，散户资金净流出8367.78万元，占总成交额3.15%。近5日资金流向一览见下表：美诺华主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082100010801.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660740245","title":"8月20日美诺华涨5.85%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2660740245","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660740245?lang=zh_cn&edition=full","pubTime":"2026-08-20 16:35","pubTimestamp":1787214910,"startTime":"0","endTime":"0","summary":"证券之星消息，8月20日美诺华涨5.85%，收盘报31.68元，换手率25.25%，成交量85.08万手，成交额26.53亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为43.1%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026082000028813.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660473498","title":"美诺华（603538）披露召开2026年第二次临时股东会通知，8月18日股价下跌1.25%","url":"https://stock-news.laohu8.com/highlight/detail?id=2660473498","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660473498?lang=zh_cn&edition=full","pubTime":"2026-08-18 22:04","pubTimestamp":1787061895,"startTime":"0","endTime":"0","summary":"截至2026年8月18日收盘，美诺华报收于30.75元，较前一交易日下跌1.25%，最新总市值为104.53亿元。该股当日开盘31.15元，最高32.28元，最低30.53元，成交额达17.97亿元，换手率为17.15%。近日，宁波美诺华药业股份有限公司发布《关于召开2026年第二次临时股东会的通知》。公告显示，公司将于2026年9月3日召开2026年第二次临时股东会，会议采用现场投票与网络投票相结合的方式，网络投票通过上海证券交易所系统进行。股权登记日为2026年8月27日。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081800042145.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660880105","title":"【机构调研记录】银河基金调研美诺华、多利科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2660880105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660880105?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:01","pubTimestamp":1786924902,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月14日披露的机构调研信息，银河基金近期对2家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。集采推动制剂放量，成为营收增长核心原因。2）多利科技 调研纪要：随着一体化压铸业务规模逐步扩大，产品结构更趋丰富，规模效应将逐步显现，盈利能力有望持续改善。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001604.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0264","BK0239","603538","001311"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660058381","title":"【机构调研记录】华宝基金调研美诺华、多利科技","url":"https://stock-news.laohu8.com/highlight/detail?id=2660058381","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660058381?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:01","pubTimestamp":1786924884,"startTime":"0","endTime":"0","summary":"证券之星消息，根据市场公开信息及8月14日披露的机构调研信息，华宝基金近期对2家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。集采推动制剂放量，成为营收增长核心原因。2）多利科技 调研纪要：随着一体化压铸业务规模逐步扩大，产品结构更趋丰富，规模效应将逐步显现，盈利能力有望持续改善。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081700001577.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0264","BK0239","001311"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660891105","title":"【私募调研记录】玄卜投资调研美诺华","url":"https://stock-news.laohu8.com/highlight/detail?id=2660891105","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660891105?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:00","pubTimestamp":1786924859,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月14日披露的机构调研信息，知名私募玄卜投资近期对1家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。CDMO订单因默沙东及新冠创新药业务增长而提升，短期资本开支不大，研发投入将逐步上升。公司强调以披露信息为准，提醒投资者不信谣不传谣。机构简介：玄卜投资（上海）有限公司成立于2014年，注册资本为人民币4,500万元。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081700001556.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660210586","title":"【私募调研记录】季胜投资调研美诺华","url":"https://stock-news.laohu8.com/highlight/detail?id=2660210586","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660210586?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:00","pubTimestamp":1786924855,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月14日披露的机构调研信息，知名私募季胜投资近期对1家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。CDMO订单因默沙东及新冠创新药业务增长而提升，短期资本开支不大，研发投入将逐步上升。公司强调以披露信息为准，提醒投资者不信谣不传谣。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081700001548.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2660105861","title":"【私募调研记录】翼虎投资调研美诺华","url":"https://stock-news.laohu8.com/highlight/detail?id=2660105861","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2660105861?lang=zh_cn&edition=full","pubTime":"2026-08-17 08:00","pubTimestamp":1786924855,"startTime":"0","endTime":"0","summary":"根据市场公开信息及8月14日披露的机构调研信息，知名私募翼虎投资近期对1家上市公司进行了调研，相关名单如下：1）美诺华 调研纪要：默沙东合作项目进入商业化阶段，宣城美诺华数据已有积极体现。高端制剂储备超70个品种，聚焦欧美及国内市场。集采推动制剂放量，成为营收增长核心原因。CDMO订单因默沙东及新冠创新药业务增长而提升，短期资本开支不大，研发投入将逐步上升。公司强调以披露信息为准，提醒投资者不信谣不传谣。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://fund.stockstar.com/RB2026081700001549.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659175359","title":"每周股票复盘：美诺华（603538）近5日4次登龙虎榜","url":"https://stock-news.laohu8.com/highlight/detail?id=2659175359","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659175359?lang=zh_cn&edition=full","pubTime":"2026-08-16 01:08","pubTimestamp":1786813691,"startTime":"0","endTime":"0","summary":"截至2026年8月14日收盘，美诺华报收于30.21元，较上周的29.2元上涨3.46%。本周，美诺华8月13日盘中最高价报35.0元。本周关注点来自交易信息汇总：美诺华近5个交易日内第4次因日换手率达20%登上龙虎榜。沪深交易所2026年8月11日公布，美诺华因相同原因登上龙虎榜，为近5个交易日内第2次上榜。股本股东变化股东户数变动截至2026年6月30日，美诺华股东户数为4.41万户，较3月31日减少8373.0户，减幅15.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081600000056.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659111033","title":"8月14日美诺华（603538）龙虎榜数据：北向资金净卖出2174.12万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659111033","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659111033?lang=zh_cn&edition=full","pubTime":"2026-08-14 17:42","pubTimestamp":1786700556,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月14日公布的交易公开信息显示，美诺华因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第4次上榜。截至2026年8月14日收盘，美诺华报收于30.21元，下跌7.25%，换手率24.38%，成交量82.16万手，成交额24.97亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净卖出2174.12万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081400029917.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659158336","title":"8月13日美诺华（603538）龙虎榜数据：北向资金净卖出1759.38万元","url":"https://stock-news.laohu8.com/highlight/detail?id=2659158336","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659158336?lang=zh_cn&edition=full","pubTime":"2026-08-13 17:37","pubTimestamp":1786613873,"startTime":"0","endTime":"0","summary":"证券之星消息，沪深交易所2026年8月13日公布的交易公开信息显示，美诺华因有价格涨跌幅限制的日换手率达到20%的前五只证券登上龙虎榜。此次是近5个交易日内第4次上榜。截至2026年8月13日收盘，美诺华报收于32.57元，下跌2.28%，换手率33.72%，成交量113.61万手，成交额38.09亿元。从龙虎榜公布的当日买卖数据来看，北向资金合计净卖出1759.38万元。深股通专用、沪股通专用为北向资金的交易席位。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300029176.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2659852461","title":"美诺华（603538）2026年中报简析：营收净利润同比双双增长，应收账款上升","url":"https://stock-news.laohu8.com/highlight/detail?id=2659852461","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2659852461?lang=zh_cn&edition=full","pubTime":"2026-08-13 06:02","pubTimestamp":1786572153,"startTime":"0","endTime":"0","summary":"据证券之星公开数据整理，近期美诺华发布2026年中报。截至本报告期末，公司营业总收入8.59亿元，同比上升26.79%，归母净利润6368.91万元，同比上升29.83%。按单季度数据看，第二季度营业总收入5.21亿元，同比上升30.02%，第二季度归母净利润3252.71万元，同比上升16.86%。本报告期美诺华应收账款上升，应收账款同比增幅达55.44%。营业成本变动幅度为32.77%,原因:营业收入增长，相应的变动成本增长。本文数据来源于美诺华2026年中报，仅供参考不构成投资建议。","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081300003414.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658973560","title":"美诺华(603538)6月30日股东户数4.41万户，较上期减少15.96%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658973560","media":"证券之星","labels":["shareholding"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658973560?lang=zh_cn&edition=full","pubTime":"2026-08-12 17:23","pubTimestamp":1786526613,"startTime":"0","endTime":"0","summary":"证券之星消息，近日美诺华披露，截至2026年6月30日公司股东户数为4.41万户，较3月31日减少8373.0户，减幅为15.96%。在化学制药行业个股中，美诺华股东户数高于行业平均水平，截至6月30日，化学制药行业平均股东户数为3.6万户。从股价来看，2026年3月31日至2026年6月30日，美诺华区间跌幅为20.42%，在此期间股东户数减少8373.0户，减幅为15.96%。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200029316.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"shareholding","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538","BK0239"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658792036","title":"8月12日美诺华涨10.00%，富国致航量化选股股票A基金重仓该股","url":"https://stock-news.laohu8.com/highlight/detail?id=2658792036","media":"证券之星","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658792036?lang=zh_cn&edition=full","pubTime":"2026-08-12 16:31","pubTimestamp":1786523480,"startTime":"0","endTime":"0","summary":"证券之星消息，8月12日美诺华涨10.00%，收盘报33.33元，换手率13.07%，成交量44.03万手，成交额14.32亿元。根据2026基金半年报公募基金重仓股数据，重仓该股的公募基金共2家，其中持有数量最多的公募基金为富国基金的富国致航量化选股股票A。苗富在任的基金产品包括:富国致弘量化选股股票A，管理时间为2025年7月22日至今，期间收益率为38.87%；富国致航量化选股股票A的前十大重仓股如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200027591.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658947688","title":"异动快报：美诺华（603538）8月12日9点33分触及涨停板","url":"https://stock-news.laohu8.com/highlight/detail?id=2658947688","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658947688?lang=zh_cn&edition=full","pubTime":"2026-08-12 09:35","pubTimestamp":1786498556,"startTime":"0","endTime":"0","summary":"证券之星8月12日盘中消息，9点33分美诺华（603538）触及涨停板。其所属行业化学制药目前上涨。领涨股为哈药股份。该股为减肥药，化学原料药，医药概念热股，当日减肥药概念上涨1.38%，化学原料药概念上涨0.66%，医药概念上涨0.58%。8月11日的资金流向数据方面，主力资金净流入2.26亿元，占总成交额8.55%，游资资金净流出1.07亿元，占总成交额4.03%，散户资金净流出1.2亿元，占总成交额4.53%。近5日资金流向一览见下表：美诺华主要指标及行业内排名如下：以上内容为证券之星据公开信息整理，仅供参考不构成投资建议。","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200009319.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658912951","title":"图解美诺华中报：第二季度单季净利润同比增长16.86%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658912951","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658912951?lang=zh_cn&edition=full","pubTime":"2026-08-12 01:16","pubTimestamp":1786468606,"startTime":"0","endTime":"0","summary":"证券之星消息，美诺华2026年中报显示，上半年度公司主营收入8.59亿元，同比上升26.79%；归母净利润6368.91万元，同比上升29.83%；扣非净利润6339.89万元，同比上升72.5%；其中2026年第二季度，公司单季度主营收入5.21亿元，同比上升30.02%；单季度归母净利润3252.71万元，同比上升16.86%；单季度扣非净利润3881.76万元，同比上升92.83%；负债率36.07%，投资收益652.17万元，财务费用2312.15万元，毛利率29.27%。财报数据概要请见下图:本文数据来源于美诺华2026年中报，仅供参考不构成投资建议。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081200001532.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658946916","title":"美诺华（603538）披露《公司章程》（2026年8月修订版），8月11日股价上涨3.77%","url":"https://stock-news.laohu8.com/highlight/detail?id=2658946916","media":"证券之星","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658946916?lang=zh_cn&edition=full","pubTime":"2026-08-11 22:01","pubTimestamp":1786456882,"startTime":"0","endTime":"0","summary":"截至2026年8月11日收盘，美诺华报收于30.3元，较前一交易日上涨3.77%，最新总市值为103亿元。该股当日开盘28.6元，最高31.42元，最低28.58元，成交额达26.48亿元，换手率为25.98%。近日，宁波美诺华药业股份有限公司发布《公司章程》。","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://stock.stockstar.com/RB2026081100037705.shtml","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"stockstar","symbols":["BK0239","603538"],"isVideo":false,"video":null,"gpt_icon":0},{"id":"2658915966","title":"公告精选︱工业富联：上半年净利润237.4亿元，同比增长95.99%；宝鼎科技：无AI覆铜板，未发现在AI服务器及算力领域的应用","url":"https://stock-news.laohu8.com/highlight/detail?id=2658915966","media":"格隆汇","labels":[],"top":-1,"itemType":null,"share":"https://www.laohunote.com/m/news/2658915966?lang=zh_cn&edition=full","pubTime":"2026-08-11 21:33","pubTimestamp":1786455196,"startTime":"0","endTime":"0","summary":"强瑞技术：拟定增募资不超过10.5亿元用于高端半导体设备精密零部件生产制造项目等","market":"sh","thumbnail":"https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375","type":0,"news_type":0,"thumbnails":["https://img7.gelonghui.com/column/2/111.png?guru_height=540&guru_width=375"],"rights":null,"property":["earning"],"language":"zh","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gelonghui.com/p/6015781","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gelonghui_highlight","symbols":["LU2097828631.EUR","LU2289578879.USD","002552","LU1781817850.SGD","LU1997245177.USD","600502","LU0456827905.SGD","BK0096","BK0117","LU0210526637.USD","LU2097828714.EUR","BK0193","BK0229","LU1580142542.USD","002145","BK0118","BK0277","BK0251","002376","LU2580892862.HKD","BK0115","BK0224","LU1497733631.SGD","LU2495084118.USD","BK0259","LU1979443071.USD","688525","BK0022","600481","601886","603538","LU1430594728.SGD","SGXZ49509284.SGD","LU2580892789.USD","LU1634259557.SGD","LU2097828557.USD","LU1934453819.USD","BK0012","BK0134","LU0051755006.USD","BK0239","LU1997245094.SGD","BK0070","301128","603271","LU1255011170.USD","600221","LU1497734951.SGD","BK0174","LU1585245621.USD","LU1634259391.SGD","BK0264","BK0257","LU2097828474.EUR","BK0101","LU1997244956.HKD","BK0214","BK0039","603758","LU1497733557.USD","300261","LU2097828805.USD","LU1522347837.USD","LU1064131003.USD","BK0073","BK0188","BK0233","LU2148510915.USD","BK0114","BK0196","BK0077","688498","BK0201","BK0080","BK0145","BK0028","BK0183","BK0001","LU1655091616.SGD","BK0180","BK0040","LU1064130708.USD","SGXZ81163826.USD","BK0015","BK0280","601138"],"isVideo":false,"video":null,"gpt_icon":0}],"profile":{"ret":0,"serverTime":1787378309543,"stockEarnings":[{"period":"1week","weight":-0.0563},{"period":"1month","weight":-0.0246},{"period":"3month","weight":-0.2056},{"period":"6month","weight":0.892},{"period":"1year","weight":0.4775},{"period":"ytd","weight":1.0827}],"compareEarnings":[{"period":"1week","weight":-0.0056},{"period":"1month","weight":0.0099},{"period":"3month","weight":-0.0505},{"period":"6month","weight":-0.0433},{"period":"1year","weight":0.0356},{"period":"ytd","weight":-0.016}],"compareStock":{"symbol":"000001.SH","name":"上证指数"},"companyName":"宁波美诺华药业股份有限公司","boardCode":"AI0027","boardName":"医药制造业","stockholders":"44076人(较上一季度减少15.96%)","perCapita":"7644股","listingDate":"2017-04-07","address":"浙江省宁波市鄞州区高新区梅墟街道菁华路777号、剑兰路1177弄10号1号楼7楼","registeredCapital":"33992万元","survey":" 宁波美诺华药业股份有限公司的主营业务是特色原料药和制剂研发、生产与销售。公司的主要产品是医药中间体、原料药、制剂。公司是中国化学制药百强企业、宁波市制造业百强企业、宁波竞争力百强企业、浙江省成长最快百强企业。","listedPrice":14.03},"APP":{"userAgent":"Mozilla/5.0 AppleWebKit/537.36 (KHTML, like Gecko; compatible; ClaudeBot/1.0; +claudebot@anthropic.com)","isDev":false,"isTTM":false,"isLaohu8Offline":false,"tenantId":"TBCN","deviceId":"web-server-community-laohu8-v3","version":"4.44.1","shortVersion":"4.44.1","platform":"web","vendor":"web","appName":"laohu8","isIOS":false,"isAndroid":false,"isTiger":false,"isTHS":false,"isWeiXin":false,"isWeiXinMini":false,"isWeiBo":false,"isQQ":false,"isBaiduSwan":false,"isBaiduBox":false,"isDingTalk":false,"isToutiao":false,"isOnePlus":false,"isHuaWei":false,"isXiaomi":false,"isXiaomiWebView":false,"isOppo":false,"isVivo":false,"isSamsung":false,"isMobile":false},"pagemeta":{"title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","keywords":"美诺华,603538,美诺华股票,美诺华股票老虎,美诺华股票老虎国际,美诺华行情,美诺华股票行情,美诺华股价,美诺华股市,美诺华股票价格,美诺华股票交易,美诺华股票购买,美诺华股票实时行情,购买美股,购买港股,港股开户,美股开户,美股交易,港股交易,开通美港股账户,老虎国际行情","social":{"og_title":"美诺华(603538)_个股概要_股票价格_最新资讯_行情走势_历史数据","og_description":"美港股上老虎。老虎社区提供美诺华(603538)今日价格,行情走势,历史数据,股票概要及实时的新闻资讯,近期大事等重要参考决策数据。","og_image":"https://static.tigerbbs.com/a0b84b8debbbce3b4440f7fdd5eed2e7"}}}